TWD 47.2
(-0.21%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 6.64 Billion TWD | -4.83% |
2022 | 6.98 Billion TWD | 17.41% |
2021 | 5.95 Billion TWD | 39.86% |
2020 | 4.25 Billion TWD | 4548.46% |
2019 | 91.52 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 6.53 Billion TWD | -1.72% |
2024 Q2 | 6.56 Billion TWD | 0.42% |
2023 Q4 | 6.64 Billion TWD | -6.92% |
2023 Q3 | 7.14 Billion TWD | 0.37% |
2023 FY | 6.64 Billion TWD | -4.83% |
2023 Q1 | 6.98 Billion TWD | -0.04% |
2023 Q2 | 7.11 Billion TWD | 1.91% |
2022 FY | 6.98 Billion TWD | 17.41% |
2022 Q4 | 6.98 Billion TWD | 0.0% |
2021 FY | 5.95 Billion TWD | 39.86% |
2020 FY | 4.25 Billion TWD | 4548.46% |
2019 FY | 91.52 Million TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Allied Biotech Corporation | 910.11 Million TWD | -630.601% |
GeneFerm Biotechnology Co., Ltd. | 282.53 Million TWD | -2253.423% |
Easywell Biomedicals, Inc. | 589.98 Million TWD | -1027.025% |
TTY Biopharm Company Limited | 3.36 Billion TWD | -97.381% |
Synmosa Biopharma Corporation | 3.62 Billion TWD | -83.294% |
Center Laboratories, Inc. | 6.78 Billion TWD | 2.014% |
Tien Liang BioTech Co., Ltd. | 161.05 Million TWD | -4028.675% |
Orient Pharma Co., Ltd. | 892.18 Million TWD | -645.287% |
InnoPharmax Inc. | 48.64 Million TWD | -13567.936% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 320.99 Million TWD | -1971.483% |
Excelsior Biopharma Inc. | 472.87 Million TWD | -1306.149% |
DV Biomed Co., Ltd. | 765.87 Million TWD | -768.199% |
Foresee Pharmaceuticals Co., Ltd. | 616.93 Million TWD | -977.803% |
Handa Pharmaceuticals, Inc. | 280.88 Million TWD | -2267.306% |
UniPharma Co., Ltd. | 37.4 Million TWD | -17678.439% |
Anxo Pharmaceutical Co., Ltd. | 1.01 Billion TWD | -554.892% |
Alar Pharmaceuticals Inc. | 76.08 Million TWD | -8638.864% |
Winston Medical Supply Co., Ltd. | 373.87 Million TWD | -1678.486% |
Mercury Biopharmaceutical Corporation | 49.72 Million TWD | -13273.251% |
Bioray Biotech Co., Ltd | 108.75 Million TWD | -6014.199% |
TSH Biopharm Corporation Limited | 133.62 Million TWD | -4876.063% |